CBmeter- a new medical device for early screening of metabolic diseases

Guarino, Maria Pedro; Brito, Gabriel; Lages, Marlene; Fonseca-Pinto, Rui; Lopes, Nuno Vieira

http://hdl.handle.net/10400.8/3544

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Guarino MP HealthIPLeiria2018.pdf		156.19 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Type 2 diabetes mellitus (T2DM) is a highly prevalent disease worldwide which is asymptomatic in about 44% of patients being critical to search for new ways of early diagnosis. Recent studies have demonstrated that the etiology of this disease may be associated with alterations in the function of the carotid body (CB), a chemosensor organ located within the bifurcation of the carotid artery. In animal models of metabolic syndrome it was observed that the CBs are overactivated, underlying diseases such as obesity, hypertension and T2DM. This discovery provided a new paradigm in the neuroendocrinology field, suggesting that diagnostic function of the CBs has predictive value for the development of metabolic diseases. Despite this fact, it is not common in clinical practice to look at the CBs as organs associated with endocrine dysfunction and we believe this is probably due to the nonexistence of a user-friendly, portable medical device that diagnosis the function of the CBs.